baber/WOPTO huggingface dataset:
Patent MX-PA01004532-A (MX)
Title: Cable closure.
Inventor: RADELET CHRISTIAAN
IPC: H02G15/113
Filed: 1999-10-19
Abstract: A cable closure comprises two half shells (1, 2) together forming an enclosed space (3) for housing a cable, and a sealing strip (6) positioned between peripheral regions of the half shells (1, 2), at least one of the shells having a removable portion (8, 9) to provide a cable entry port (12). A cable sealing device (14) may be positioned at the cable entry port (12) such that a seal is provided between the sealing strip (6) and each half shell (1, 2) and the cable entering through the port (12).
Patent MX-PA01007613-A (MX)
Title: Inducible expression system for use in plants.
Inventor: JEPSON IAN
IPC: C12N15/82
Filed: 1999-12-22
Abstract: The use of an agriculturally acceptable hydrolysable ester such as a compound of formula (I) in which R1 and R2 are defined in the application, in the control of expression of a plant gene, said control being effected by an inducible promoter which requires for activation, the presence of an exogenous chemical which may comprise an alcohol, wherein hydrolysis of said agriculturally acceptable ester results in the production of said alcohol. Formulations of these esters are also described and claimed.
Patent MX-PA01011905-A (MX)
Title: Novel compounds, their use and preparation.
Inventor: NILSSON BJOERN
IPC: C07D413/12
Filed: 2000-05-19
Abstract: The invention relates to compounds of general formula (I) wherein Ar is optionally substituted aryl or heteroaryl; A is (i) -O-, -S-, -SO2-, -NH-, (ii) a C1-4-alkyl- or C1-6-acyl-substituted nitrogen atom or (iii) a C1-8-alkylene chain or a heteroalkylene chain having 2 to 8 chain atoms, which optionally contains at least one unsaturation, and which may be substituted and/or contain a bridge to form a saturated or partially or fully unsaturated ring having 3-8 ring members; B is -C(R4)(R5)-, -OC(R4)(R5)-, -N(R6)C(R4)(R5)-, -N(R6)-O-, -S- or -SO2-; R is optionally substituted C3-8-cycloalkyl, aryl or heteroaryl; R1 is (i) a saturated or unsaturated azacyclic or aminoazacyclic ring, or a saturated diazacyclic or aminodiazacyclic ring, which has 4 to 7 ring members, or a saturated aminoazabicyclic, azabicyclic or diazabicyclic ring which has 7 to 10 ring members, which rings optionally are substituted in one or more positions, or a group -[C(R4)(R5)]xN(R2a)(R3a)]; R2a, R3a, R4, R5, R6 and x are as defined in the claims, and n is 0 or 1; and pharmaceutically acceptable salts, hydrates and prodrug forms thereof. The compounds may be prepared by per se conventional methods and can be used for treating a human or animal subject suffering from a serotonin-related disorder, such as eating disorders, especially obesity, memory disorders, schizophrenia, mood disorders, anxiety disorders, pain, sexual dysfunctions, and urinary disorders. The invention also relates to such use as well as to pharmaceutical compositions comprising a compound of formula (I).
Patent MX-PA02000532-A (MX)
Title: Low density well cement compositions.
Inventor: PEREIRA BURTON
IPC: C04B24/38
Filed: 2000-07-12
Abstract: Improved low density well cement slurry compositions are formed by the addition of a free-fluid inhibitor additive to a mixture comprising a hydraulic cement and water. Suitable free-fluid inhibitors are hydroxy ethyl cellulose polymers having a cps value in the range of from about 5000 to about 50,000.
Patent MX-PA02000698-A (MX)
Title: Method of reducing colour loss from dyed hair using organic amino compounds.
Inventor: PAUL ALFRED CORNWELLG
IPC: A61K8/43
Filed: 2000-07-10
Abstract: A method for reducing colour loss from hair treated with an oxidative composition, such as an oxidative hair dye, the method comprising the step of contacting the hair, either prior to or after treatment of the hair with the oxidative composition, with a colour protective composition comprising an organic amino compound selected from: (i) basic amino acids; (ii) urea; (iii) guanidine; (iv) salts and/or derivatives of any of (i) to (iii); (v) mixtures of any of (i) to (iv).
Patent MX-PA02000773-A (MX)
Title: Method for producing 4-cyano-2-aminomethylthiazol.
Inventor: MONIKA KNOPP
IPC: C07D277/20
Filed: 2000-07-11
Abstract: The present invention relates to a method for producing 2-amino-methyl-4-cyano-thiazol, including a step in which an aminonitrile is stirred with a cystein ester.
Patent MX-PA02001949-A (MX)
Title: Method for isolating and purifying grass pollen allergens.
Inventor: ROLAND SUCK
IPC: C07K14/415
Filed: 2000-08-18
Abstract: The invention relates to a method for quickly and effectively isolating and purifying five, namely the group 1, 2, 3, 10 and 13 allergens from grass pollen. The purification of said grass pollen is based on the inventive combination of hydrophobic interaction chromatography, gel filtration and cation exchange chromatography. The proteins obtained by the inventive method facilitate an improved diagnosis of pollen allergies and are used in pharmaceutical preparations for the therapy of pollenogenic diseases.
Patent MX-PA02002205-A (MX)
Title: Adapter for a feeding system.
Inventor: GLENN FOURNIE
IPC: A61J1/10
Filed: 2000-08-30
Abstract: An adapter (10) utilized to interconnect a fluid container (88) and a tubing set (90) having a retractable spike (14) and a rolling seal diaphragm (18) for establishing fluid flow communication between a nutrition container and an administration tubing set (90) while maintaining a fluid tight seal. The rolling seal diaphragm (18) includes a rolling seal portion (80) which sealingly engages the retractable spike (14) which remains engaged with the spike body (12) while the spike is biased between an engaged position and a disengaged position.
Patent MX-PA02007675-A (MX)
Title: Male contraceptive formulation comprising norethisterone.
Inventor: OETTEL MICHAEL
IPC: A61K9/70
Filed: 2001-02-15
Abstract: A formulation for male contraception comprising a progestin prossessing both estrogenic and androgenic properties is remarkably effective for spermatogenesis suppression in males. The progestin Norethisterone (NET), particularly its derivatives Norethisterone acetate and Norethisterone enanthate in sufficient doses induce oligozoospermia or azoospermia in males. Formulations further comprising an androgen, such as a testosterone derivative such as a testosterone ester, particularly testosterone undecanoate, are especially effective male contraceptive formulations.
Patent MX-PA02011908-A (MX)
Title: Gap welding process.
Inventor: THELEN RICHARD L
IPC: B23K13/01
Filed: 2001-06-01
Abstract: A gap welding process (10) for manipulating a movable robotic welder (30) for making a weld between two or more substantially immovable work pieces (51) using a higher level programming language (20). The gap welding process (10) performs a data transfer routine which takes spreadsheet data (18) representing expected variables, runs a data conversion program (20) that creates weld program data including point position, user frames (34 and 36), weld schedule, seam tracking schedule, weave schedule, azimuth orientation, travel speed, wait time, weave type and number of digital output control data. The gap welding process (10) also performs a gap-sensing routine (28) for actual weld gap measuring by using the robotic welder (30) to touch specific locations on pieces forming the gap or fixturing to produce weld variance data. The gap welding process (10) then uses a weld control program in conjunction with the weld program data (22), weld variance data (26), and feedback data (44) that is gathered during the welding process to determine and perform the correct manipulation required to produce torch movements to accurately weld the gap (32).
Patent MX-PA02012858-A (MX)
Title: Human papilloma virus treatment.
Inventor: GOLDSTONE STEPHEN
IPC: C12N15/09
Filed: 2001-06-26
Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
Patent MX-PA03001948-A (MX)
Title: Multi-layered inside lining piece.
Inventor: ZIEGER MICHAEL
IPC: B60R13/02
Filed: 2001-09-01
Abstract: A multishell interior trim part for a side door of a passenger car consists of a function carrier interior shell ( 1 ) of a polypropylene, epoxy resin or polyurethane reinforced by natural fibers, and an outer shell ( 10 ) which partially or completely covers the interior shell ( 1 ) as seen by the passengers.
Patent MX-PA03003234-A (MX)
Title: Contact lens with encapsulated light-reflective particles.
Inventor: LYNCH CHRISTOPHER
IPC: G02C7/02
Filed: 2001-10-11
Abstract: A contact lens having visually perceptible light-reflective particles encapsulated within the lens body. The particles reflect light in an irregular manner, producing a sparkle or glitter effect.
Patent MX-PA03008597-A (MX)
Title: Path sealed software object conditional access control.
Inventor: DOUGLAS MAKOFKA
IPC: H04N21/462
Filed: 2002-03-18
Abstract: A method of securing information. The method comprises: obtaining a path to the information; and performing a security check regarding the path.
Patent MX-PA03009636-A (MX)
Title: Spring assembly and method for manufacturing the same.
Inventor: TOSHIE FUEKI
IPC: B21D39/00
Filed: 2003-10-21
Abstract: A manufacturing method of a spring assembly, assembles an annular plate (1A,1B) and a compression coil spring (2). The method includes forming a protrusion (4A,4B) having a tapered portion on the annular plate, and inserting a punch (8) including a first portion having a larger diameter than an inner diameter of a tip end of the tapered portion from the tip end side into the protrusion to expand the tip end of the tapered portion. The expansion of the tip end of the tapered portion involves expanding a base portion of the protrusion, which extends the tapered portion and has a larger inner diameter than that of the tip end of the tapered portion, along a surface of an end turn of the compression coil spring.
Patent MX-PA03011503-A (MX)
Title: Xerographic printing system with magnetic seal between development and transfer.
Inventor: ROGER D MASHAM
IPC: G03G15/09
Filed: 2003-12-11
Abstract: In a xerographic development apparatus using a magnetic brush formed from magnetic carrier particles, a magnetic strip disposed downstream of the development zone along the direction of motion of the photoreceptor retains a separate, small brush of carrier particles near the photoreceptor. The brush acts as a barrier separating a flow of "dirty" air (laden with airborne toner particles) upstream of the strip, and a flow of clean air downstream of the strip.
Patent MX-PA04001578-A (MX)
Title: Insect control device for prolonged treatment of animals containing coumaphos and diazinon.
Inventor: ROBERT G ARTHER
IPC: A01M29/30
Filed: 2002-08-28
Abstract: Annoying insects are controlled by attaching an insect control device to the body of the animal to be treated. The insect control device is a molded article, preferably in the form of an ear tag, which has been formed from a powder mixture of coumaphos and diazinon, polyvinyl chloride, and a plasticizer. The coumaphos and diazinon are generally used in an amount that would prolong the insecticidal activity without detracting from the suitability of the device.
Patent MX-PA04004172-A (MX)
Title: Method and system for secure communication.
Inventor: FENTON CHARLES S
IPC: G06F21/55
Filed: 2002-10-30
Abstract: A method and system for secure communication is presented. A virtual private proxy is generated based on an agreement between a first entity and a second entity. A first virtual private proxy is associated with the first entity and a second virtual private proxy is associated with the second entity. Data associated with the first entity is monitored at the virtual private proxy. Whether the data violates the agreement is determined and communication of the data from the first virtual private proxy to the second virtual private proxy is disallowed when the data violates the agreement.
Patent MX-PA04004557-A (MX)
Title: Fungicidal composition based on a pyridylmethylbenzamide derivative and a valinamide derivative.
Inventor: THOMAS WEGMANN
IPC: A01N25/30
Filed: 2002-11-13
Abstract: Fungicidal compositions comprising: a) at least one pyridylmethylbenzamide derivative of formula (I), in which the various radicals are as defined in the description; and b) at least one compound (II) of the valinamide type, preferably iprovalicarb or N1-[(R) -1-(6-fluoro -2-benzothiazolyl) ethyl]-N2 -isopropoxycarbonyl-L -valinamide; and their agriculturally acceptable isomers and addition salts with an acid. Method for the curative or preventive control of phytopathogenic fungi of crops using an effective and non-phytotoxic quantity of one of these fungicidal compositions.
Patent MX-PA04005838-A (MX)
Title: Benzothia(dia)zine derivatives and their use as ampa modulators.
Inventor: PIERRE LESTAGE
IPC: A61P25/14
Filed: 2002-12-20
Abstract: The invention concerns compounds of formula (I), wherein: R1 represents a hydroxy group or a RCO-O- group; R2 represents a hydrogen, halogen atom, a hydroxy group or a R'CO-O group; R, R', identical or different, represent an optionally substituted alkyl group; R3 represents a hydrogen atom, an alkyl group or a cycloalkyl group; A represents a CR4R5 group or a NR4 group; R4 represents a hydrogen atom or an alkyl group; their isomers and their addition salts to a pharmaceutically acceptable acid or base. Said compounds are useful as AMPA modulators for treating or preventing memory and learning disorders associated with age, anxiety or depression syndromes, gradual neurodegenerative diseases, Alzheimer's disease, Pick's disease, Huntington's chorea, schizophrenia, sequels of acute neurodegenerative diseases, ischemia sequels and epilepsy sequels.
Patent MX-PA04008056-A (MX)
Title: Rf point of sale and delivery method and system using communication with remote computer and having features to read a large number of rf tags.
Inventor: GEDIMINAS VIDUGIRIS
IPC: G06Q10/00
Filed: 2003-02-18
Abstract: A method and system for providing point-of-sale and point-of-delivery and/or distribution of products in a restricted access unit near the customer. The method and system utilize products equipped with radio frequency tags and reduce the effects of energy sharing, shadowing, and nulls. In one embodiment, a plurality of RF tagged products are placed within a refrigerator, cabinet, or other micro-warehouse that has a door or opening that can detect access to the micro-warehouse. In one embodiment, one or more antennas are positioned within the door. Each antenna may have a transmission line of sight and be configured to emit a signal at predefined frequencies. Each antenna generates an electromagnetic field within the micro-warehouse. In one embodiment, the products are positioned in one or more bins, compartments, or similar devices located within the micro-warehouse such that at least two of the plurality of products are spaced a distance from each other to reduce energy sharing. The electromagnetic field is moved or altered within the micro-warehouse through the use of reflectors, devices that move the antennas, or other mechanisms.
Patent MX-PA04009968-A (MX)
Title: Oral suspension of active principle microcapsules.
Inventor: REMI MEYRUEIX
IPC: A61K9/10
Filed: 2003-04-07
Abstract: The invention concerns liquid pharmaceutical formulations, for oral delivery, with modified release of active principle(s) excluding amoxicillin and consisting of suspensions of coated particles of active principles (microcapsules). The microcapsules constituting the dispersed phase of the suspension are designed, according to the invention, to enable modified release of the active principle(s), in accordance with a profile which remains unaltered during the shelf life of the liquid suspension. Therefor, the invention consists in selecting a coating composition specific to the microcapsules consisting of at least four components enabling preservation of said microcapsules in water without altering their properties of modified release of the active principle, said liquid phase being furthermore saturated with active principle(s).
Patent MX-PA04010925-A (MX)
Title: Formulations containing amiodarone and sulfoalkyl ether cyclodextrin.
Inventor: GAYED ATEF A
IPC: A61K47/48
Filed: 2003-04-29
Abstract: The present invention provides aqueous parenteral formulations containing an antiarrhythmic agent, such as amiodarone, and a sulfoalkyl ether cyclodextrin. The liquid formulations are clear, sterilizable, and chemically and physically stable. The liquid formulations do not require a surfactant and do not precipitate upon dilution with distilled water or other pharmaceutically acceptable liquid carrier. The sulfoalkyl ether cyclodextrin-containing formulation provides significant advantages over other cyclodextrin-containing formulations of amiodarone. The formulation can be prepared in acidic, neutral and slightly basic medium while providing acceptable concentrations of amiodarone suitable for parental administration. An SAE-CD-containing formulation of amiodarone can be provided in liquid form or as a reconstitutable powder. Moreover, highly concentrated solutions exceeding 200 mg of amiodarone per mL can be prepared. Solutions can be made either dilutable or non-dilutable with water at room temperature or under conditions typically encountered in the clinic.
Patent MX-PA05000010-A (MX)
Title: Efficacy enhancers for germicides.
Inventor: TRAN YVONNE
IPC: A01N25/02
Filed: 2004-12-17
Abstract: Disclosed herein are germicidal compositions and methods of using the germicidal compositions for disinfection and sterilization. In one aspect, a germicidal composition includes a germicidal dialdehyde and an efficacy enhancing halide salt to enhance the efficacy of the dialdehyde. One such composition may include water, phthalaldehyde, and an alkali metal halide salt to enhance the efficacy of the phthalaldehyde. In another aspect, a germicidal composition may include a carbonated germicidal solution containing dissolved phthalaldehyde. A method of forming the carbonated solution may include introducing carbon dioxide into the composition.
Patent MX-PA05002507-A (MX)
Title: Methods and apparatus for replicating original objects.
Inventor: HARRINGTON BRUCE E
IPC: B29C33/38
Filed: 2003-06-12
Abstract: Methods and apparatus for producing cast articles (63, 2400, 2452) with characteristics of original objects such as a stone panel (204, 1200). The cast articles can replicate the contours, textures, 5 and colors of all or a portion of the original object and can be made in any shape or size and specifically can be formed to simulate rock walls, carved stone architecture details, and other construction components normally created by stone masons or sculptors on site and at a high cost. The processes used in making the cast articles include the production of a series of molds (600, 1000, 1300, 2200, 2450, M, 55). The molds seek to replicate the size, shape, contour, and surface texture of an original object with or without modifications to the original object.
Patent MX-PA05004672-A (MX)
Title: Process for controlling the fatty acid chain composition of triglycerides and use thereof.
Inventor: ULRIK ENGELRUD
IPC: C07C67/54
Filed: 2003-10-30
Abstract: The present invention relates to a process for controlling the fatty acid chain composition of triglycerides wherein a feed stream comprises a mixture of triglycerides containing at least one long chain. Said mixture is substantially free of trishort chain triglycerides and it is treated in at least two fractionation steps to fractionate between long chain triglycerides at temperatures above 200 ¦C and pressures between 0.01 and 10 Pa, wherein one of said steps fractionates between trilong chain triglycerides and mono- and dilong chain triglycerides and the other one of said steps fractionates between monolong chain triglycerides and dilong chain triglycerides. The process can be used for the providing of target triglycerides having a controlled fatty acid chain distribution.
Patent MX-PA05005511-A (MX)
Title: Thermal energy management in electrochemical fuel cells.
Inventor: COLE JONATHAN
IPC: H01M8/04
Filed: 2003-11-20
Abstract: A fuel cell assembly supplies water and water vapour by-product to a cooling water circuit delivered to a thermal storage tank from which it can be recycled to the fuel cell stack as direct input to the membrane electrode assemblies, for use as fuel/oxidant preheat and/or direct water injection to the membrane electrode assembly. The purity of water delivered to the membrane is thereby assured. The thermal storage tank allows for a decoupling of the thermal and electrical loads on the fuel cell stack in a combined heat and electrical power delivery unit. Under low external electrical loads, the fuel cell stack and its cooling circuit may be used at high capacity to provide hot water.
Patent MX-PA05007971-A (MX)
Title: Spirally wound tube with enhanced inner diameter stiffness, and method of making same.
Inventor: BELLUM CLIFF A
IPC: B31C3/00
Filed: 2003-03-21
Abstract: Wide ply gaps (18) are intentionally introduced into one or more plies (14) in a radially intermediate zone of the wall of a spirally wound tube (10). Each ply having wide ply gaps (18) is narrower than the width that would ordinarily be employed at a given spiral winding angle to achieve a butt joint between adjacent edges of consecutive turns of the ply (14), and the ply (14), and the ply is wound at that given spiral winding angle in such a manner that gaps (18) are defined between the adjacent edges of the consecutive turns of the ply (14). The wide ply gaps have the effect of increasing the compliance of the intermediate zone of the tube wall in the radial direction. Such increased radial compliance has been found to improve the ID stiffness of the tube (10) relative to a tube constructed of the same materials but having no ply gaps (18) in the intermediate zone.
Patent MX-PA05008042-A (MX)
Title: Surgical instrument incorporating an electrically actuated articulation locking mechanism.
Inventor: SHELTON FREDERICK E IV
IPC: A61B17/072
Filed: 2005-07-28
Abstract: A surgical instrument particularly suited to endoscopic use articulates an end effector by including an articulation mechanism in an elongate shaft that incorporates an electrically actuated polymer (EAP) articulation locking mechanism actuator. Thereby, additional options for articulation become feasible, especially those that are actively powered and would otherwise dissipate heat and power if required to maintain position. Alternatively, a mechanically actuated articulation mechanism may be designed with reduced strength, and thus size, since the EAP articulation lock mechanism assists in preventing back driving after articulation. Versions of a. EAP articulation locking mechanism lock a pivoting articulation joint and others lock a flexible neck articulation joint.